BET-BAY 002
BET-BAY 002 is a potent BET inhibitor; shows efficacy in a multiple myeloma model.
Product Specifications
CAS Number
1588521-78-1
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/BET-BAY-002.html
Purity
99.80
Solubility
DMSO : ≥ 50 mg/mL
Smiles
CC1=NN=C(C[C@H]2C3=NN=C(C)N3C4=CC=CC=C4C(C5=CC=C(Cl)C=C5)=C2)O1
Molecular Formula
C22H18ClN5O
Molecular Weight
403.86
References & Citations
[1]Evans DM, et al. Exposure time versus cytotoxicity for anticancer agents.Cancer Chemother Pharmacol. 2019 Aug;84 (2) :359-371.|[2]Jung M, et al. Targeting BET bromodomains for cancer treatment. Epigenomics. 2015;7 (3) :487-501.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402884-100 1x 100 µL
CD6 (Negative Marker of T-regulatory Cells) (C6/2884R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400452-500 1x 500 µL
Vimentin (VM452), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details